Live Breaking News & Updates on Shorla Oncology Announced

Stay updated with breaking news from Shorla oncology announced. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Shorla Oncology Announces FDA Filing Acceptance of New Drug Application to Treat Certain Forms of Leukemia and Other Cancers

CAMBRIDGE, Mass., April 08, 2024 Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the company’s New Drug Application (NDA) for SH-201, the first palatable oral liquid of the related chemotherapeutic agent to treat certain forms of leukemia and other cancers. The Agency assigned a Prescription Drug User Fee Act ("PDUFA") action date of November 30, 2024. ....

United States , United Kingdom , Sharon Cunningham , Orlaith Ryan , Drug Administration , Dawn Communications , American Cancer Society , Us Ireland Pharmaceutical Company , Shorla Oncology Announced , Oral Liquid Drug , Ireland Pharmaceutical , Certain Types , Shorla Oncology , New Drug Application , Prescription Drug User Fee Act , Chief Executive Officer , Myeloid Leukemia , Lymphoblastic Leukemia , Chief Technical Officer , T Cell Leukemia , Cancer Facts ,